According to Sorrento Therapeutics 's latest financial reports and stock price the company's current number of shares outstanding is 551,281,000. At the end of 2023 the company had 551,281,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 0.55 B | 22.07% |
2022 | 0.45 B | 50.9% |
2021 | 0.29 B | 19.13% |
2020 | 0.25 B | 92.06% |
2019 | 0.13 B | 11.77% |
2018 | 0.11 B | 52.2% |
2017 | 76.88 M | 16.16% |
2016 | 66.19 M | 77.33% |
2015 | 37.32 M | 30.82% |
2014 | 28.53 M | 101.86% |
2013 | 14.13 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Karyopharm Therapeutics
KPTI | 114,401,000 | -79.25% | ๐บ๐ธ USA |
Exelixis EXEL | 300,757,000 | -45.44% | ๐บ๐ธ USA |
Dicerna Pharmaceuticals DRNA | 73,916,400 | -86.59% | ๐บ๐ธ USA |